Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cefalexin 500mg tablets
0501021L0AAAHAH
|
Cefalexin | Cefalexin | Infections | 26,522 |
|
Hiprex 1g tablets
0501130H0BBAAAA
|
Hiprex | Methenamine hippurate | Infections | 25,927 |
|
Cefalexin 250mg tablets
0501021L0AAAGAG
|
Cefalexin | Cefalexin | Infections | 25,657 |
|
Phenoxymethylpenicillin 250mg/5ml oral solution sugar free
0501011P0AAASAS
|
Phenoxymethylpenicillin (Penicillin V) | Phenoxymethylpenicillin (Penicillin V) | Infections | 25,576 |
|
Nitrofurantoin 100mg tablets
0501130R0AAAEAE
|
Nitrofurantoin | Nitrofurantoin | Infections | 25,466 |
|
Azithromycin 200mg/5ml oral suspension
0501050A0AAABAB
|
Azithromycin | Azithromycin | Infections | 25,220 |
|
Amoxicillin 250mg capsules
0501013B0AAAAAA
|
Amoxicillin | Amoxicillin | Infections | 22,819 |
|
Itraconazole 100mg capsules
0502010C0AAAAAA
|
Itraconazole | Itraconazole | Infections | 21,813 |
|
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free
0501013K0AAAGAG
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 20,212 |
|
Nitrofurantoin 100mg capsules
0501130R0AAABAB
|
Nitrofurantoin | Nitrofurantoin | Infections | 19,117 |
|
Co-amoxiclav 250mg/125mg tablets
0501013K0AAAAAA
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 18,870 |
|
Ciprofloxacin 250mg tablets
0501120L0AAAAAA
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | 15,093 |
|
Mebendazole 100mg/5ml oral suspension
0505010D0AAAAAA
|
Mebendazole | Mebendazole | Infections | 14,977 |
|
Clindamycin 150mg capsules
0501060D0AAABAB
|
Clindamycin hydrochloride (Systemic) | Clindamycin hydrochloride | Infections | 14,697 |
|
Valaciclovir 500mg tablets
0503021A0AAAAAA
|
Valaciclovir | Valaciclovir | Infections | 14,569 |
|
Doxycycline 50mg capsules
0501030I0AAAAAA
|
Doxycycline hyclate (Antibacterial) | Doxycycline hyclate | Infections | 14,403 |
|
Erythromycin ethyl succinate 250mg/5ml susp sugar free
0501050H0AAAMAM
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 14,389 |
|
Co-trimoxazole 160mg/800mg tablets
0501080D0AAAJAJ
|
Co-trimoxazole | Co-trimoxazole(Trimethoprim/sulfamethoxazole) | Infections | 14,366 |
|
Erythromycin ethyl succinate 250mg/5ml oral suspension
0501050H0AAABAB
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 14,353 |
|
Flucloxacillin 250mg/5ml oral solution sugar free
0501012G0AAAQAQ
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 13,790 |
|
Mebendazole 100mg chewable tablets sugar free
0505010D0AAADAD
|
Mebendazole | Mebendazole | Infections | 11,877 |
|
Ofloxacin 200mg tablets
0501120P0AAAAAA
|
Ofloxacin (Systemic) | Ofloxacin | Infections | 11,383 |
|
Cefalexin 125mg/5ml oral suspension
0501021L0AAACAC
|
Cefalexin | Cefalexin | Infections | 11,017 |
|
Cefalexin 250mg/5ml oral suspension
0501021L0AAADAD
|
Cefalexin | Cefalexin | Infections | 10,499 |
|
Aciclovir 200mg dispersible tablets
0503021C0AAAGAG
|
Aciclovir (Systemic) | Aciclovir | Infections | 10,178 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.